Blueprint Medicines Corp
NASDAQ:BPMC

Watchlist Manager
Blueprint Medicines Corp Logo
Blueprint Medicines Corp
NASDAQ:BPMC
Watchlist
Price: 97.175 USD 0.3% Market Closed
Market Cap: 6.2B USD
Have any thoughts about
Blueprint Medicines Corp?
Write Note

Blueprint Medicines Corp
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Blueprint Medicines Corp
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Blueprint Medicines Corp
NASDAQ:BPMC
Cash from Financing Activities
$358.9m
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.8B
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$5.3B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
8%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Blueprint Medicines Corp's Cash from Financing Activities?
Cash from Financing Activities
358.9m USD

Based on the financial report for Sep 30, 2024, Blueprint Medicines Corp's Cash from Financing Activities amounts to 358.9m USD.

What is Blueprint Medicines Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
1%

Over the last year, the Cash from Financing Activities growth was 238%. The average annual Cash from Financing Activities growth rates for Blueprint Medicines Corp have been 12% over the past three years , 1% over the past five years .

Back to Top